CGM in Patients With ED's

Completed

Conditions studied: Anorexia Nervosa Restricting Type, Anorexia Nervosa, Binge Eating/Purging Type, ARFID, Avoidant Restrictive Food Intake Disorder

In brief

To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).

Key facts

Study ID

NCT05603481

Run by

Denver Health and Hospital Authority

People needed

50

Starts

2023-05-09

Expected to finish

2024-07-02

Last updated by the study team

2025-02-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 18-65 and meet the DSM-V criteria for AN-R or AN-BP or ARFID
• Admission %IBW ≤ 75%

You may not qualify if…

• Diagnosed with an eating disorder other than AN-R or AN-BP or ARFID
• %IBW > 75% on admission
• Inability to give informed consent to participate/lacks decisional capacity
• Unable to follow the study protocol
• Transferred to the unit on a mental health hold/short term certification
• Treatment team refusal of patient's participation

Where it is running

• Denver Health and Hospital Authority — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.